Dopamine d2 Receptor anticorps (C-Term)
Aperçu rapide pour Dopamine d2 Receptor anticorps (C-Term) (ABIN2255722)
Antigène
Voir toutes Dopamine d2 Receptor (DRD2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 306-336, C-Term
-
Réactivité croisée
- Humain, Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo
-
Attributs du produit
- DRD2, CT (DRD2, D(2) dopamine receptor, Dopamine D2 receptor)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- DRD2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 306-336 amino acids from the C-terminal region of human DRD2.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))
-
Autre désignation
- DRD2
-
NCBI Accession
- NP_057658, NP_000786
-
UniProt
- P14416
-
Pathways
- Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Inositol Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Feeding Behaviour, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity
Antigène
-